Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…
Novartis will discontinue studies of an experimental lung-cancer cancer drug because of disappointing trial results.
Continue reading Novartis Halts Lung Cancer Drug Study
Novartis Halts Lung Can…
The results of a late-stage trial show Menveo could offer protection against meningitis — an infection of the brain and spinal cord. Now, the drugmaker intends to file Menveo for use in infants in the U.S. and Europe.
…
French pharmaceutical giant Sanofi-Aventis says its multiple sclerosis drug teriflunomide significantly cut relapses in patients who took the once-daily oral treatment.
Continue reading Sanofi Says MS Drug Redu…
Female employees of Citigroup are paid less, get fewer promotions, but fired first, according to a gender discrimination lawsuit brought by six women against the bank yesterday. The bank responded, saying that the women’s alleg…